Testing effectiveness (Phase 2)UnknownNCT05207904
What this trial is testing
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Who this might be right for
Non-Small Cell Squamous Lung CancerBrain Metastases
Sun Yat-sen University 41